• Home
  • Company
  • Newsroom
  • Press Release Archive
  • Boehringer Ingelheim Vetmedica, Inc., a Market-Leading Manufacturer of Animal Vaccines, Celebrates Opening of New, Global Packaging and Distribution Warehouse in KC Animal Health Corridor
August 26, 2014

Boehringer Ingelheim Vetmedica, Inc., a Market-Leading Manufacturer of Animal Vaccines, Celebrates Opening of New, Global Packaging and Distribution Warehouse in KC Animal Health Corridor

Boehringer Ingelheim Vetmedica, Inc., (BIVI) is hosting city officials, community partners and employees at the grand opening ceremony of its new, global packaging and distribution warehouse in St. Joseph, Mo., today, Wednesday, August 27 at 2 p.m. with tours of the new facility following the ceremony from 3 p.m. to 5 p.m. The 261,000-square-foot warehouse, located at 5701 Providence Hill Drive, will streamline the process of packaging, material handling and distribution of biological vaccines and pharmaceuticals to more than 50 countries around the world.

Construction on the new consolidated distribution center began in 2012 with an investment of $28.7 million and will have 261,000 square feet, the size of approximately four football fields, of operating space at opening and is designed to meet current requirements and allow for future expansion of biological manufacturing capabilities over the next 10 years with an additional 100,000 square feet available for future growth.

Installed in the facility are many energy conserving features including motion sensor lights, high efficiency chillers and boilers, variable frequency drives on motors, low water usage fixtures and solar panels installed by Kansas City Power & Light.

“Our new Packaging and Distribution Warehouse allows for future growth,” says Dr. Albrecht Kissel, president and CEO of Boehringer Ingelheim Vetmedica, Inc. “This new facility will allow us to meet the needs of our customers we serve and prepares us for even further growth in the future.”

About Boehringer Ingelheim

Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim’s culture. Involvement in social projects, caring for the employees and their families and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors of all Boehringer Ingelheim’s endeavors.

With nearly 3,000 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about $1.46 billion (1.07 billion euros) in 2013. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 10% of net sales of the Animal Health business in R&D.

 

Media Contact

Rene Ward

Director, U.S. Animal Health Communications
3902 Gene Field Road
St. Joseph, Missouri 64506